Sargent Bickham Lagudis’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$59 Buy
+15
New +$59 ﹤0.01% 1037